abstract |
The present invention relates to the provision of a heterocyclic fused compound having an enteropeptidase inhibitory action and the use of the compound as a drug for the treatment or prevention of obesity, diabetes mellitus, etc. In particular, the compound represented by the following formula (I): where each symbol is as defined in this document, or Salt from it and the use of the compound is presented as a drug for the treatment or prevention of obesity, diabetes mellitus, etc. |